1012-129 Dual angiotensin-II suppression with angiotensin-converting enzyme inhibitor and irbesartan improves submaximal exercise time without changes in exercise-induced neurohumoral response in patients with congestive heart failure

Martine Blanchet(Montreal Heart Institute), Michel White(Montreal Heart Institute), Anique Ducharme(Montreal Heart Institute), Normand Racine(Montreal Heart Institute), André Roof(Montreal Heart Institute), Richard Sheppard(Jewish General Hospital), Jacques de Champlain(Université de Montréal), Hélène Créo, Jean‐Claude Tardif(Montreal Heart Institute), Pierré Sirois(Université Laval), Daniel Curnier(Montreal Heart Institute), Lucette Whittom(Montreal Heart Institute)
Journal of the American College of Cardiology
March 1, 2004
10.1016/s0735-1097(04)90674-2
Cited by 1

Related Papers

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis
|JAMA|2006|2k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k